NanoStem Cell Division announced today it has entered into joint research and
licensing agreements with the UK Centre for Tissue Engineering (UKCTE) at the
University of Liverpool in Liverpool, England, and the Centre of Molecular NanoMetrology
at the University of Strathclyde in Glasgow, Scotland, for the development of
modified surfaces for manipulation of stem cell differentiation. Dr. John Hunt
at the UKCTE at the University of Liverpool and Dr. Duncan Graham at the Centre
of Molecular NanoMetrology at the University of Strathclyde will act as principal
investigators for the collaboration.
"We are extremely excited to join forces with these two esteemed institutions,"
said Jim Hussey, chief executive officer of NanoInk. "We are eager to pursue
the commercial potential of using nanotechnology to control stem cell function,
particularly in the area of regenerative medicine. Each organization brings
a distinct area of expertise to the process and it is our hope that the knowledge
we obtain through our collaborative approach will propel our stem cell application
and capabilities in the area of regenerative medicine."
In January 2009, NanoInk launched the NanoStem Cell Division, which is aimed
at providing a highly reliable, renewable source of differentiated adult stem
cells. Leveraging NanoInk's proprietary Dip Pen Nanolithography® (DPN®)
technology, it is now possible to produce differentiated homogenous stem cell
populations which will lead to faster and more efficient drug discovery and
development processes, with substantial cost savings. For more information about
the NanoStem Cell Division, see www.nanoink.net/NanoStem_about.htm.